Selling, General, and Administrative Costs: Perrigo Company plc vs HUTCHMED (China) Limited

A Tale of Two Companies: SG&A Expenses Over Time

In the ever-evolving landscape of global business, understanding the financial health of companies is crucial. Selling, General, and Administrative (SG&A) expenses are a key indicator of a company's operational efficiency. This chart compares the SG&A expenses of Perrigo Company plc and HUTCHMED (China) Limited from 2014 to 2023.

Perrigo, a leading global healthcare supplier, consistently outpaces HUTCHMED in SG&A expenses, reflecting its expansive operations. In 2023, Perrigo's SG&A expenses were approximately 1.27 billion, marking a 9% increase from 2014. Meanwhile, HUTCHMED, a prominent biopharmaceutical company, saw its SG&A expenses grow by nearly 400% over the same period, reaching around 133 million in 2023.

This data highlights Perrigo's stable yet high operational costs, while HUTCHMED's rapid growth in expenses suggests aggressive expansion strategies. Investors and analysts can glean insights into each company's strategic priorities and market positioning from these trends.